Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians

European Journal of Surgical Oncology

Volumn 37, Issue 8, 2011, Pages 727-733

  Mittal, R D ^a   Srivastava, P ^a   Mittal, T ^a   Verma, A ^a   Jaiswal, P K ^a   Singh, V ^a   Mandal, R K ^a   Mandhani, A ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Bacillus Calmette Guerin; Bladder cancer; Haplotype; Polymorphism

Indexed keywords

BCG VACCINE; CASPASE 3; CASPASE 5; DEATH RECEPTOR 4;

ADULT; ALLELE; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; CASE-CONTROL STUDIES; CASPASE 3; CASPASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 79960179105     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.05.013     Document Type: Article

References (24)

1. G.I. Evan, and K.H. Vousden Proliferation, cell cycle and apoptosis in cancer Nature 411 2001 342 348 (Pubitemid 32467043)
2. S. Bouralexis, D.M. Findlay, and A. Evdokiou Death to the bad guys: targeting cancer via Apo2L/TRAIL Apoptosis 10 2005 35 51 (Pubitemid 40575634)
3. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770 776
4. S.G. Hymowitz, H.W. Christinger, and G. Fuh Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5 Mol Cell 4 1999 563 571 (Pubitemid 29531136)
5. J.J. Koornstra, M. Jalving, and F.E. Rijcken Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction Eur J Cancer 41 2005 1195 1202 (Pubitemid 40725579)
6. J.J. Koornstra, J.H. Kleibeuker, and C.M. van Geelen Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas J Pathol 200 2003 327 335 (Pubitemid 36827307)
7. A. Hazra, R.M. Chamberlain, H.B. Grossman, Y. Zhu, M.R. Spitz, and X. Wu Death receptor 4 and bladder cancer risk Cancer Res 63 2003 1157 1159 (Pubitemid 36348687)
8. Y.M. Ulybina, ESh Kuligina, and N.V. Mitiushkina Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer Cancer Lett 278 2009 183 191
9. M. Wang, M. Wang, G. Cheng, Z. Zhang, G. Fu, and Z. Zhang Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer Mutat Res 661 2009 85 92
10. S. Seitz, P. Wassmuth, and J. Fischer Mutation analysis and mRNA expression of trail-receptors in human breast cancer Int J Cancer 102 2002 117 128 (Pubitemid 35168023)
11. M.J. Fisher, A.K. Virmani, and L. Wu Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer Clin Cancer Res 7 2001 1688 1697 (Pubitemid 32708637)
12. S.H. Lee, M.S. Shin, and H.S. Kim Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma Oncogene 20 2001 399 403 (Pubitemid 32142330)
13. R. Gangwar, A. Mandhani, and R.D. Mittal Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population Ann Surg Oncol 16 2009 2028 2034
14. M. Colombel, M. Soloway, and H. Akaza Epidemiology, staging, grading and risk stratification of bladder cancer Eur Urol Suppl 7 2008 618 626
15. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1988 1215
16. K. Chen, H. Zhao, and Z. Hu CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck Clin Cancer Res 14 2008 6343 6349
17. B. Frank, K. Hemminki, and K.S. Shanmugam Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk Carcinogenesis 26 2005 1975 1977 (Pubitemid 41631272)
18. G. MacPherson, C.S. Healey, and M.D. Teare Association of a common variant of the CASP8 gene with reduced risk of breast cancer J Natl Cancer Inst 96 2004 1866 1869 (Pubitemid 40081324)
19. B. Frank, K.S. Shanmugam, and L. Beckmann Death receptor 4 variants and colorectal cancer risk Cancer Epidemiol Biomarkers Prev 15 2006 2002 2005 (Pubitemid 44664282)
20. K. Kim, M.J. Fisher, S.Q. Xu, and W.S. El-Deiry Molecular determinants of response to TRAIL in killing of normal and cancer cells Clin Cancer Res 6 2000 335 346 (Pubitemid 30111448)
21. F. Martinon, and J. Tschopp Inflammatory caspases and inflammasomes: master switches of inflammation Cell Death Differ 14 2007 10 22 (Pubitemid 44911890)
22. Y.H. Soung, E.G. Jeong, and C.H. Ahn Mutational analysis of caspase 1, 4, and 5 genes in common human cancers Hum Pathol 39 2008 895 900
23. L.M. Dong, P. Brennan, and S. Karami An analysis of growth, differentiation and apoptosis genes with risk of renal cancer PLoS One 24 2009 4
24. G.L. Bond, W. Hu, and E.E. Bond A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 119 2004 591 602 (Pubitemid 39535748)